Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial

Juliet C. Gray(University of Southampton), Lucas Moreno(Vall d'Hebron Hospital Universitari), G.A. Amos Burke(Inserm), Ruth Ladenstein(St Anna Children's Hospital), Grace Holt(University of Birmingham), Soledad Gallego(Vall d'Hebron Hospital Universitari), Aurora Castellano, Dominique Valteau‐Couanet(Institut Gustave Roussy), C. Michel Zwaan(Hôpital Saint-Michel), Keith Wheatley(Cancer Research UK Clinical Trials Unit), Antony Ng(Bristol Royal Hospital for Children), Adela Cañete(Universitat de València), Martin Elliott(Cardiff University), Charlotte Firth(Cancer Research UK Clinical Trials Unit), Guy Makin(Royal Manchester Children's Hospital), Nicolas U. Gerber(University Children's Hospital Zurich), Jennifer Laidler(University of Birmingham), Estelle Thébaud(University of Padua), Anne Sophie Defachelles(Centre Oscar Lambret), Lisa Howell(Alder Hey Children's NHS Foundation Trust), Marion Gambart(Hôpital des Enfants), Sucheta Vaidya(Royal Marsden Hospital), Cormac Owens(Children's Health Ireland at Crumlin), Andrew D.J. Pearson(Pearson (United Kingdom)), Deborah A. Tweddle(Great North Children's Hospital), Pamela Kearns(National Institute for Health and Care Research), Sally L. George(Royal Marsden NHS Foundation Trust), Bénédicte Brichard(Cliniques Universitaires Saint-Luc), Bram De Wilde(Ghent University Hospital), Anthony McCarthy(Royal Belfast Hospital for Sick Children), Natasha K. A. van Eijkelenburg(Princess Máxima Center), Louis Chesler(Institute of Cancer Research), Rebekah Weston(University of Birmingham), Sarah Jannier, Ricardo López Almaraz(BioCruces Health research Institute), Alba Rubio‐San‐Simón(Hospital del Niño), Lynley V. Marshall(Royal Marsden Hospital), Karsten Nysom(Copenhagen University Hospital), Gudrun Schleiermacher, Giuseppe Barone(Great Ormond Street Hospital), Simon Gates(Oxford Brookes University), V. V. Moroz(University of Birmingham), Dermot Murphy(NHS Greater Glasgow and Clyde), Dave Hobin(Birmingham Women's Hospital), Dan Yeomanson(Sheffield Children's Hospital), Nadège Corradini(Institut d’Hématologie et d’Oncologie Pédiatrique)
Journal of Clinical Oncology
December 12, 2025
Cited by 8


Related Papers